These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21705067)

  • 1. Glycaemia and heart failure in diabetes types 1 and 2.
    Opie LH
    Lancet; 2011 Jul; 378(9786):103-4. PubMed ID: 21705067
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis.
    Kar D; Gillies C; Zaccardi F; Webb D; Seidu S; Tesfaye S; Davies M; Khunti K
    Cardiovasc Diabetol; 2016 Nov; 15(1):158. PubMed ID: 27881170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2008--The year of the big studies about the therapy of type-2-diabetes. ACCORD, ADVANCE, VADT, and the UKPDS 10-year follow-up data].
    Schatz H
    MMW Fortschr Med; 2009 Mar; 151(12):42-3. PubMed ID: 19475859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological surveillance of diabetes mellitus: point of view of the diabetologist].
    Grimaldi A
    Ann Biol Clin (Paris); 1999; 57(4):458-62. PubMed ID: 10432369
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension.
    Taniguchi A; Fukushima M; Sakai M; Nagata I; Nagasaka S; Doi K; Kinoshita H; Kanda N; Tokuyama K; Nakai Y
    Diabetes Care; 2000 Jun; 23(6):856-7. PubMed ID: 10841009
    [No Abstract]   [Full Text] [Related]  

  • 7. Aiming for the best control of glycemia in patients with heart failure and type 2 diabetes the "sweet spot".
    Weinrauch LA; Lewis EF
    J Am Coll Cardiol; 2009 Jul; 54(5):429-31. PubMed ID: 19628118
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic complications: current challenges and opportunities.
    Nickerson HD; Dutta S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):375-9. PubMed ID: 22752737
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart failure in the diabetic patient.
    Bell DS
    Cardiol Clin; 2007 Nov; 25(4):523-38; vi. PubMed ID: 18063157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.
    Turk HM; Buyukberber S; Sevinc A; Ak G; Ates M; Sari R; Savli H; Cigli A
    Diabetes Care; 2000 Jun; 23(6):864-7. PubMed ID: 10841017
    [No Abstract]   [Full Text] [Related]  

  • 11. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
    MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disordered cerebral hemodynamics in diabetic patients (based on myelographic data)].
    Cherniĭ VI; Mikhaĭlichenko TE; Bessmertnaia EV; Koval' EN
    Lik Sprava; 1999 Mar; (2):59-63. PubMed ID: 10424044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreasing complications in type 2 diabetes.
    Greenawald MH; Schaffer RS; Jeremiah MP
    J Fam Pract; 1998 Apr; 46(4):278-9. PubMed ID: 9564363
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries for patients. The relationship between blood sugar control and cardiovascular disease in patients with diabetes.
    Ann Intern Med; 2004 Sep; 141(6):I21. PubMed ID: 15381537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of the determination of glycosylated hemoglobins in diabetes mellitus].
    Grinshpun MN; Mazovetskiĭ AG; Galenok VA; Dikker VE
    Probl Endokrinol (Mosk); 1983; 29(6):80-5. PubMed ID: 6419224
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes and peripheral vascular disease.
    Huysman E; Mathieu C
    Acta Chir Belg; 2009 Oct; 109(5):587-94. PubMed ID: 19994800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
    Stettler C; Allemann S; Jüni P; Cull CA; Holman RR; Egger M; Krähenbühl S; Diem P
    Am Heart J; 2006 Jul; 152(1):27-38. PubMed ID: 16824829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy.
    Kawamori R; Kamado K; Kamada T
    J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.